Prophylactic anti-staphylococcal antibiotics for cystic fibrosis

QR Code

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis

Background Staphylococcus aureus causes pulmonary infection in young children with cystic fibrosis. Prophylactic antibiotics are prescribed hoping to prevent such infection and lung damage. Antibiotics have adverse effects and long-term use might lead to infection with Pseudomonas aeruginosa. Obje...

Full description

Bibliographic Details
Main Authors:	Smyth, Alan R., Walters, Sarah
Format:	Article
Published:	Wiley 2014
Online Access:	https://eprints.nottingham.ac.uk/31684/

Similar Items

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2016)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)

Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics
by: Huckle, Anthony W., et al.
Published: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Association of Antibiotics, Airway Microbiome and Inflammation in Infants with Cystic Fibrosis.
by: Pittman, J., et al.
Published: (2017)

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)

Prophylactic antibiotics for the prevention of cellulitis
by: Thomas, K.S.
Published: (2007)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [5 February 2016]
by: Smyth, Alan R., et al.
Published: (2016)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Working with the patient and clinical community to deliver clinical research in cystic fibrosis. James Lind CF Phase II
by: Smith, S.J., et al.
Published: (2018)

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [updated 13 July 2016]
by: Smyth, Alan R., et al.
Published: (2016)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Prophylactic Antibiotic Use in Breast Cancer Surgery Patients
by: Habak, Jawad, et al.
Published: (2013)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)

Who benefits when parents administer intravenous antibiotics, at home, to children with cystic fibrosis? A critical review.
by: Walsh, Daniel
Published: (2009)

POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

METABOLOMIC RESPONSE OF HEALTHY AND CYSTIC FIBROSIS EPITHELIUM TO RHINOVIRUS
by: Agudelo-Romero, P., et al.
Published: (2019)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Respiratory viral infections in Western Australians with cystic fibrosis
by: Brestovac, Brian, et al.
Published: (2020)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Gilchrist, Francis J., et al.
Published: (2015)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

An evaluation of the High Frequency Digit Triplet Test as a screening tool for early detection of hearing loss in individuals with Cystic Fibrosis. Protocol v2.1.
by: Smyth, Alan R., et al.
Published: (2016)

sTREM-1 is elevated in cystic fibrosis and correlates with proteases
by: Forrester, D.L., et al.
Published: (2017)